Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Datum Research, LLC | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider.
The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.
We have designed a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider.
The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.
Follow-up surveys will be given at 30, 60, and 90 days. These surveys will be collected by e-mail or follow-up calls from Datum Research, LLC, contract research organization.
Data collection for this study will be derived through the 4 patient surveys (initial, 30 day, 60 day, and 90 day) and the prescription written by the provider.
The survey study will enroll patients until December 31, 2014, or until sufficient numbers have been achieved.
Rahm Foundation will continue the study until:
Datum Research will need to have access to the prescription to see what compound was prescribed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pain management | patients undergoing transdermal treatment for pain | ||
| Scar care | patients undergoing transdermal treatment for scars | ||
| Wound care | patients undergoing transdermal treatment for wounds | ||
| UDT | patients receiving urinary drug tests |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Change in pain survey results from baseline at 30 days | Survey on pain management | baseline and 30 days |
| Change in pain survey results from baseline at 60 days | Survey on pain management | baseline and 60 days |
| Change in pain survey results from baseline at 90 days | Survey on pain management | baseline and 90 days |
| Change in scar care survey results from baseline at 30 days | Survey on scar care | baseline and 30 days |
| Change in scar care survey results from baseline at 60 days | Survey on scar care | baseline and 60 days |
| Change in scar care survey results from baseline at 90 days | Survey on scar care | baseline and 90 days |
| Change in wound care survey results from baseline at 30 days | Survey on wound care | baseline and 30 days |
| Change in wound care survey results from baseline at 60 days | Survey on wound care | baseline and 60 days |
| Measure | Description | Time Frame |
|---|---|---|
| Change in pain survey results from 30 days at 60 days | Survey on pain management | 30 days and 60 days |
| Change in pain survey results from 30 days at 90 days | Survey on pain management |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients who are given a prescription for topical compound for pain, scar care, or wound care, and agree to complete the surveys
or
Patients who are given a UDT and agree to complete the surveys.
Patients will be recruited into the study if their providers prescribe a topical cream for pain, scar care or wound care or if the provider performs a UDT prior to treatment or surgery. The providers will follow their office procedure for UDT. If they perform a UDT and the patient agrees to participate in the survey study, they will have the patient complete the surveys.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Christina R Cook, PhD | Contact | 615-712-9574 | ccook@blueprintpathways.com | |
| Risa Tyo, PharmD | Contact | 615-712-9574 | rtyo@datumcro.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Blueprint Pathways | Recruiting | Nashville | Tennessee | 37203 | United States |
Not provided
| Label | URL |
|---|---|
| Blueprint Pathways | View source |
| The Rahm Foundation | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| D002921 | Cicatrix |
| D014947 | Wounds and Injuries |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D005355 | Fibrosis |
Not provided
Not provided
Not provided
Not provided
Not provided
| Change in wound care survey results from baseline at 90 days | Survey on wound care | baseline and 90 days |
| Change in UDT survey results from baseline at 30 days | Survey on urinary drug testing | baseline and 30 days |
| Change in UDT survey results from baseline at 60 days | Survey on urinary drug testing | baseline and 60 days |
| Change in UDT survey results from baseline at 90 days | Survey on urinary drug testing | baseline and 90 days |
| 30 days and 90 days |
| Change in pain survey results from 60 days at 90 days | Survey on pain management | 60 days and 90 days |
| Length of hospital stay | if applicable | at baseline |
| Change in scar care survey results from 30 days at 60 days | Survey on scar care | 30 days and 60 days |
| Change in scar care survey results from 30 days at 90 days | Survey on scar care | 30 days and 90 days |
| Change in scar care survey results from 60 days at 90 days | Survey on scar care | 60 days and 90 days |
| Change in wound care survey results from 30 days at 60 days | Survey on wound care | 30 days and 60 days |
| Change in wound care survey results from 30 days at 90 days | Survey on wound care | 30 days and 90 days |
| Change in UDT survey results from 60 days at 90 days | Survey on urinary drug testing | 60 days and 90 days |
| Change in UDT survey results from 30 days at 60 days | Survey on urinary drug testing | 30 days and 60 days |
| Change in UDT survey results from 30 days at 90 days | Survey on urinary drug testing | 30 days and 90 days |
| D010335 | Pathologic Processes |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009422 | Nervous System Diseases |